1
NURS 251 Pharmacology Final Exam Portage
Learning Review Actual Exam 2026/2027 –
Complete Exam-Style Questions with Detailed
Rationales | Pass Guaranteed – A+ Graded
[SECTION 1: Pharmacokinetics & Pharmacodynamics — Questions 1-15]
Q1: A patient is prescribed a medication that undergoes significant "first-pass metabolism." The
nurse understands this means:
A. The drug is metabolized in the liver before reaching systemic circulation, requiring a higher
oral dose.
B. The drug is rapidly absorbed in the stomach for immediate effect.
C. The drug is excreted unchanged by the kidneys.
D. The drug is injected intravenously for 100% bioavailability.
Correct Answer: A
Rationale: First-pass metabolism refers to the partial inactivation of an oral drug in the liver
before it enters the systemic circulation. This significantly reduces the bioavailability of the oral
dose compared to parenteral administration. IV administration (D) bypasses the liver initially,
offering 100% bioavailability.
Q2: To monitor peak and trough levels of a medication effectively, when should the nurse draw a
"trough" level?
A. Immediately before administering the next dose.
B. 30 minutes after the IV infusion has started.
C. 1 hour after the dose is given orally.
D. Anytime during the dosing interval.
Correct Answer: A
,2
Rationale: A trough level represents the lowest concentration of the drug in the body, drawn just
before the next scheduled dose to ensure the drug is not accumulating to toxic levels. Peak levels
are drawn after the drug is absorbed/infused to ensure it is high enough to be therapeutic.
Q3: Which route of medication administration provides the fastest onset of action and 100%
bioavailability?
A. Oral (PO)
B. Intramuscular (IM)
C. Intravenous (IV)
D. Subcutaneous (SQ)
Correct Answer: C
Rationale: Intravenous administration delivers medication directly into the bloodstream,
providing 100% bioavailability and the fastest onset of action. Oral (A) has the slowest onset and
lowest bioavailability due to absorption and first-pass metabolism.
Q4: A highly protein-bound drug (e.g., warfarin) is administered to a patient with low albumin
levels (hypoalbuminemia). What is the potential clinical effect?
A. Decreased free drug and therapeutic failure.
B. Increased free drug and risk of toxicity.
C. No change in drug activity.
D. Enhanced metabolism of the drug.
Correct Answer: B
Rationale: Protein-bound drugs attach to albumin; only the unbound "free" drug is active. If
albumin levels drop, more of the drug becomes "free" (unbound), increasing the pharmacologic
effect and potentially leading to toxicity even at standard doses.
Q5: A patient taking St. John's wort (a CYP450 inducer) is prescribed a medication metabolized
by the same enzyme system. What is the likely outcome?
,3
A. Increased serum levels of the medication leading to toxicity.
B. Decreased serum levels of the medication reducing its effectiveness.
C. No interaction between St. John's wort and the medication.
D. Enhanced renal excretion of the medication.
Correct Answer: B
Rationale: CYP450 inducers increase the activity of liver enzymes, accelerating the breakdown
of drugs. This leads to subtherapeutic levels of the co-administered drug and treatment failure.
Inhibitors (like ketoconazole) would have the opposite effect (increased levels/toxicity).
Q6: The "Therapeutic Index" of a drug is defined as:
A. The dosage required to treat a specific condition.
B. The ratio between the toxic dose and the therapeutic dose.
C. The duration of action of the drug.
D. The percentage of drug bound to plasma proteins.
Correct Answer: B
Rationale: The Therapeutic Index measures the safety of a drug; it is the ratio between the toxic
dose (TD50) and the effective dose (ED50). A narrow therapeutic index indicates a small margin
of safety (high risk of toxicity), while a wide index indicates a safer drug.
Q7: Which of the following correctly describes the action of a pharmacologic "agonist"?
A. Binds to a receptor and prevents the natural chemical from binding.
B. Binds to a receptor and produces a biological response similar to the natural chemical.
C. Blocks the enzyme from metabolizing a drug.
D. Destroys the receptor on the cell surface.
Correct Answer: B
, 4
Rationale: An agonist binds to a receptor and activates it, mimicking the effect of the body's
natural neurotransmitters or hormones. Option A describes an antagonist. Options C and D
describe mechanisms not related to receptor agonism.
Q8: A drug has a "half-life" of 4 hours. If the initial dose is 100mg, how much of the drug will
remain in the body after 12 hours (assuming first-order kinetics)?
A. 12.5 mg
B. 25 mg
C. 50 mg
D. 75 mg
Correct Answer: A
Rationale: Half-life is the time it takes for the drug's plasma concentration to decrease by 50%.
After 4 hours, 50mg remains (50%); after 8 hours, 25mg remains; after 12 hours (3 half-lives),
12.5mg remains (50% of 25mg).
Q9: Which organ is primarily responsible for the metabolism of most drugs?
A. Kidneys
B. Liver
C. Heart
D. Lungs
Correct Answer: B
Rationale: The liver is the primary site of drug metabolism, primarily via the Cytochrome P450
(CYP450) enzyme system, which converts lipid-soluble drugs into water-soluble metabolites for
easier excretion. The kidneys (A) are primarily responsible for excretion.
Q10: Grapefruit juice acts as a CYP3A4 enzyme inhibitor. If a patient drinks grapefruit juice
while taking a statin metabolized by CYP3A4, what may occur?
A. The statin will be metabolized faster.
NURS 251 Pharmacology Final Exam Portage
Learning Review Actual Exam 2026/2027 –
Complete Exam-Style Questions with Detailed
Rationales | Pass Guaranteed – A+ Graded
[SECTION 1: Pharmacokinetics & Pharmacodynamics — Questions 1-15]
Q1: A patient is prescribed a medication that undergoes significant "first-pass metabolism." The
nurse understands this means:
A. The drug is metabolized in the liver before reaching systemic circulation, requiring a higher
oral dose.
B. The drug is rapidly absorbed in the stomach for immediate effect.
C. The drug is excreted unchanged by the kidneys.
D. The drug is injected intravenously for 100% bioavailability.
Correct Answer: A
Rationale: First-pass metabolism refers to the partial inactivation of an oral drug in the liver
before it enters the systemic circulation. This significantly reduces the bioavailability of the oral
dose compared to parenteral administration. IV administration (D) bypasses the liver initially,
offering 100% bioavailability.
Q2: To monitor peak and trough levels of a medication effectively, when should the nurse draw a
"trough" level?
A. Immediately before administering the next dose.
B. 30 minutes after the IV infusion has started.
C. 1 hour after the dose is given orally.
D. Anytime during the dosing interval.
Correct Answer: A
,2
Rationale: A trough level represents the lowest concentration of the drug in the body, drawn just
before the next scheduled dose to ensure the drug is not accumulating to toxic levels. Peak levels
are drawn after the drug is absorbed/infused to ensure it is high enough to be therapeutic.
Q3: Which route of medication administration provides the fastest onset of action and 100%
bioavailability?
A. Oral (PO)
B. Intramuscular (IM)
C. Intravenous (IV)
D. Subcutaneous (SQ)
Correct Answer: C
Rationale: Intravenous administration delivers medication directly into the bloodstream,
providing 100% bioavailability and the fastest onset of action. Oral (A) has the slowest onset and
lowest bioavailability due to absorption and first-pass metabolism.
Q4: A highly protein-bound drug (e.g., warfarin) is administered to a patient with low albumin
levels (hypoalbuminemia). What is the potential clinical effect?
A. Decreased free drug and therapeutic failure.
B. Increased free drug and risk of toxicity.
C. No change in drug activity.
D. Enhanced metabolism of the drug.
Correct Answer: B
Rationale: Protein-bound drugs attach to albumin; only the unbound "free" drug is active. If
albumin levels drop, more of the drug becomes "free" (unbound), increasing the pharmacologic
effect and potentially leading to toxicity even at standard doses.
Q5: A patient taking St. John's wort (a CYP450 inducer) is prescribed a medication metabolized
by the same enzyme system. What is the likely outcome?
,3
A. Increased serum levels of the medication leading to toxicity.
B. Decreased serum levels of the medication reducing its effectiveness.
C. No interaction between St. John's wort and the medication.
D. Enhanced renal excretion of the medication.
Correct Answer: B
Rationale: CYP450 inducers increase the activity of liver enzymes, accelerating the breakdown
of drugs. This leads to subtherapeutic levels of the co-administered drug and treatment failure.
Inhibitors (like ketoconazole) would have the opposite effect (increased levels/toxicity).
Q6: The "Therapeutic Index" of a drug is defined as:
A. The dosage required to treat a specific condition.
B. The ratio between the toxic dose and the therapeutic dose.
C. The duration of action of the drug.
D. The percentage of drug bound to plasma proteins.
Correct Answer: B
Rationale: The Therapeutic Index measures the safety of a drug; it is the ratio between the toxic
dose (TD50) and the effective dose (ED50). A narrow therapeutic index indicates a small margin
of safety (high risk of toxicity), while a wide index indicates a safer drug.
Q7: Which of the following correctly describes the action of a pharmacologic "agonist"?
A. Binds to a receptor and prevents the natural chemical from binding.
B. Binds to a receptor and produces a biological response similar to the natural chemical.
C. Blocks the enzyme from metabolizing a drug.
D. Destroys the receptor on the cell surface.
Correct Answer: B
, 4
Rationale: An agonist binds to a receptor and activates it, mimicking the effect of the body's
natural neurotransmitters or hormones. Option A describes an antagonist. Options C and D
describe mechanisms not related to receptor agonism.
Q8: A drug has a "half-life" of 4 hours. If the initial dose is 100mg, how much of the drug will
remain in the body after 12 hours (assuming first-order kinetics)?
A. 12.5 mg
B. 25 mg
C. 50 mg
D. 75 mg
Correct Answer: A
Rationale: Half-life is the time it takes for the drug's plasma concentration to decrease by 50%.
After 4 hours, 50mg remains (50%); after 8 hours, 25mg remains; after 12 hours (3 half-lives),
12.5mg remains (50% of 25mg).
Q9: Which organ is primarily responsible for the metabolism of most drugs?
A. Kidneys
B. Liver
C. Heart
D. Lungs
Correct Answer: B
Rationale: The liver is the primary site of drug metabolism, primarily via the Cytochrome P450
(CYP450) enzyme system, which converts lipid-soluble drugs into water-soluble metabolites for
easier excretion. The kidneys (A) are primarily responsible for excretion.
Q10: Grapefruit juice acts as a CYP3A4 enzyme inhibitor. If a patient drinks grapefruit juice
while taking a statin metabolized by CYP3A4, what may occur?
A. The statin will be metabolized faster.
